Emergency coronary artery surgery after failed PTCA: Myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 6, 1998, Pages 333-338

  Hekmat, K ^a   Clemens, R M ^a   Mehlhorn, U ^a   Geissler, H J ^a   Kuhn Regnier F ^a   De Vivie, E R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute myocardial ischemia; Beta blocker; Emergency CABG; Failed PTCA; Myocardial protection

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SURGERY; EMERGENCY SURGERY; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032440918     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1010248     Document Type: Article

References (21)

1. Detre KM, Holes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1990;82:739-50.
2. Gaul G. Hollmann J, Simpfendorfer C, Franco I. Acute occlusion in multiple lesion coronary angtoplasty: frequency and management. J Am Coll Cardiol. 1989;13:283-8.
3. Simpfendorfer C, Belardi J, Bellamy G. Galan K, Franco I, Hollman J. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1987;59:267-9.
4. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 1988;77:372-9.
5. Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors, therapeutic options and long-term outcome of abrupt reclosure. Am J Cardiol. 1988;G 61 -6.
6. Edwards FH, Bellamy RF, Burger JR, Cohen A, Thompson LN, Barry MJ, Weston L. True emergency coronary artery bypass surgery. Ann Thorac Surg. 1990;49:603-11.
7. De Feyter PJ, Van den Brand M, Jaarman G, Van Domburg R, Serruys PW, Suryapranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation. 1991;83:927-36.
8. Bottner RK, Wallace RB, Visner MS, et al. Reduction of myocardial infarction after emergency coronary artery bypass grafting for failed coronary angioplasty with use of a normothermic reperfusion cardioplegia protocol. J Thorac Cardiovasc Surg. 1991;101:1069-75.
9. Talley JD, Weintraub WS, Roubin GS, et al. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery: in-hospital and late clinical outcome at 5 years. Circulation. 1990;82:1203-13.
10. Lazar HL, Faxon DP, Paone G, Rajaii-Khorasani A, Jacobs AK, Fallon MP, Shemin RJ. Changing profiles of failed coronary angioplasty patients: impact on surgical results. Ann Thorac Surg. 1992;53: 269-73.
11. Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher CR Jr. Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty: a 10-year experience. Ann Surg. 1992;215:425-34.
12. Borkon AM, Failing TL, Piehler JM, Killen DA, Hoskins ML, Reed WA. Risk analysis of operative intervention for failed coronary angioplasty. Ann Thorac Surg. 1992;54:884-91.
13. Beyersdorf F, Sarai K, Maul FD, Wendt T, Satter P. Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg. 1991;102:856-66,
14. Beyersdorf F, Mitrev Z, Sarai K, Eckel L, Klepzig H, Maul FD, Ihnken K, Satter P. Changing patterns of patients undergoing emergency surgical revascularization for acute coronary occlusion: importance of myocardial protection techniques. J Thorac Cardiovasc Surg. 1993;106:137-48.
15. Sweeney MS, Frazier OH. Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg. 1992;54: 1065-70.
16. Kirshenbaum JM, Kloner RF, McGowan N. Antman EM. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988;12:773-80.
17. Campbell CA, Przyklenk K, Kloner RA. Infarct size reduction: a review of the clinical trials. J Clin Pharmacol. 1986;26:317-29.
18. Roth E, Torok B. Effect of the ultrashort-acting β-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res Cardiol. 1991;86:422-33.
19. Spahn DR, Frasco PE, White WD, Smith LR, McRae RL, Leone BJ. Is esmolol cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis. J Am Coll Cardiol. 1993;21:809-21.
20. Mooss AN, Hilleman DE, Mohiuddin SM, Hunter CB. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to β-blocker therapy. Ann Pharmacother. 1994;28:701-3.
21. Laub GW, Muralidharan S, Reibman J, Fernandez J, et al. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model. J Thorac Cardiovasc Surg. 1996; 111 :1085-91.